Author

M. A. Watson

Observed name: M. Watson

Institution: Washington University in St. Louis

Observed institution: Washington University in St. Louis

OpenAlex ID: A5126228458

3RO Improved identification of high-risk node-negative breast cancer using a multimodal clinical, pathologic, and genomic model in the TAILORx Trial

2026 · F.M. Howard, K. Nguyen, et al. · ESMO Open

Abstract PS3-08-13: Exploratory analysis of palbociclib benefit in the PALLAS trial by SETERPR index and prior chemotherapy regimens (ABCSG-42/AFT-05/BIG-14-13)

2026 · O. Metzger, P. O'Brien, et al. · Clinical Cancer Research

Abstract PS1-13-17: Rna-based immune features associated with benefit from distinct microtubule inhibitor therapy for metastatic her2-negative breast cancer: a post hoc analysis of the calgb 40502 (alliance) phase iii randomized clinical trial

2026 · E. K. Blige, K. V. Ballman, et al. · Clinical Cancer Research

Abstract PS2-07-27: Qutils: open-source image-based infiltrating immune cell detection and outcomes in calgb 40502, calgb 40603, and calgb 40601 phase iii breast cancer clinical trials

2026 · M. Vater, R. Salgado, et al. · Clinical Cancer Research

Works count: 4

Citation count:

H-index:

I10-index: